

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | surfactant homeostasis (GO:0043129) | 8.73669503 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 8.65357927 |
| 3 | triglyceride catabolic process (GO:0019433) | 7.99039326 |
| 4 | chemical homeostasis within a tissue (GO:0048875) | 7.09069447 |
| 5 | neutral lipid catabolic process (GO:0046461) | 7.06365768 |
| 6 | acylglycerol catabolic process (GO:0046464) | 7.06365768 |
| 7 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 6.85534319 |
| 8 | keratan sulfate catabolic process (GO:0042340) | 6.55158882 |
| 9 | pattern specification involved in kidney development (GO:0061004) | 6.36049648 |
| 10 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 6.34728704 |
| 11 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 6.11730199 |
| 12 | transcytosis (GO:0045056) | 6.02331824 |
| 13 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 5.96002826 |
| 14 | negative regulation of cell fate specification (GO:0009996) | 5.81729401 |
| 15 | response to dietary excess (GO:0002021) | 5.66811597 |
| 16 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 5.63597397 |
| 17 | regulation of sequestering of triglyceride (GO:0010889) | 5.37490455 |
| 18 | ovulation from ovarian follicle (GO:0001542) | 5.24550880 |
| 19 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 5.19581353 |
| 20 | regulation of gonadotropin secretion (GO:0032276) | 5.17520519 |
| 21 | glycerolipid catabolic process (GO:0046503) | 5.09786367 |
| 22 | bone trabecula formation (GO:0060346) | 5.08186519 |
| 23 | glomerular filtration (GO:0003094) | 5.02965511 |
| 24 | embryonic cranial skeleton morphogenesis (GO:0048701) | 4.83330813 |
| 25 | extracellular fibril organization (GO:0043206) | 4.69668359 |
| 26 | negative regulation of amino acid transport (GO:0051956) | 4.68861634 |
| 27 | positive regulation of glomerulus development (GO:0090193) | 4.61712030 |
| 28 | polyol transport (GO:0015791) | 4.58818264 |
| 29 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 4.57406821 |
| 30 | lateral sprouting from an epithelium (GO:0060601) | 4.55029357 |
| 31 | renal filtration (GO:0097205) | 4.54820933 |
| 32 | response to pheromone (GO:0019236) | 4.54144687 |
| 33 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 4.42572312 |
| 34 | negative regulation of cell fate commitment (GO:0010454) | 4.38571846 |
| 35 | convergent extension (GO:0060026) | 4.33811387 |
| 36 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 4.28992932 |
| 37 | digestive tract morphogenesis (GO:0048546) | 4.28859242 |
| 38 | regulation of establishment of planar polarity (GO:0090175) | 4.27354664 |
| 39 | chondrocyte development (GO:0002063) | 4.24919135 |
| 40 | positive regulation of catenin import into nucleus (GO:0035413) | 4.21698015 |
| 41 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 4.20266373 |
| 42 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.14926539 |
| 43 | craniofacial suture morphogenesis (GO:0097094) | 4.12499779 |
| 44 | lipid storage (GO:0019915) | 4.08507434 |
| 45 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.08209521 |
| 46 | mesenchymal cell proliferation (GO:0010463) | 4.07836834 |
| 47 | fibril organization (GO:0097435) | 4.05221098 |
| 48 | cranial suture morphogenesis (GO:0060363) | 4.04501885 |
| 49 | cell migration involved in heart development (GO:0060973) | 4.03364711 |
| 50 | cellular response to leptin stimulus (GO:0044320) | 4.02978967 |
| 51 | diacylglycerol metabolic process (GO:0046339) | 4.02026009 |
| 52 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.01681234 |
| 53 | cellular response to epinephrine stimulus (GO:0071872) | 4.01144710 |
| 54 | negative regulation of chondrocyte differentiation (GO:0032331) | 4.00716924 |
| 55 | regulation of cell fate specification (GO:0042659) | 4.00409590 |
| 56 | regulation of mesoderm development (GO:2000380) | 3.99737078 |
| 57 | cellular response to vitamin (GO:0071295) | 3.98597856 |
| 58 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.98324687 |
| 59 | negative regulation of fatty acid transport (GO:2000192) | 3.97617087 |
| 60 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.96368816 |
| 61 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.94982525 |
| 62 | collagen fibril organization (GO:0030199) | 3.92900553 |
| 63 | regulation of cholesterol storage (GO:0010885) | 3.92644486 |
| 64 | regulation of lipoprotein metabolic process (GO:0050746) | 3.86530993 |
| 65 | adult feeding behavior (GO:0008343) | 3.85876529 |
| 66 | lung lobe morphogenesis (GO:0060463) | 3.81660476 |
| 67 | head development (GO:0060322) | 3.79380864 |
| 68 | extracellular regulation of signal transduction (GO:1900115) | 3.79037756 |
| 69 | extracellular negative regulation of signal transduction (GO:1900116) | 3.79037756 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 3.77410957 |
| 71 | response to vitamin E (GO:0033197) | 3.76081234 |
| 72 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.74626007 |
| 73 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.74334544 |
| 74 | cGMP-mediated signaling (GO:0019934) | 3.73755730 |
| 75 | hemidesmosome assembly (GO:0031581) | 3.73677586 |
| 76 | non-canonical Wnt signaling pathway (GO:0035567) | 3.73391768 |
| 77 | negative regulation of stem cell proliferation (GO:2000647) | 3.71688754 |
| 78 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.70984909 |
| 79 | cell proliferation involved in kidney development (GO:0072111) | 3.67932297 |
| 80 | lipid particle organization (GO:0034389) | 3.67708548 |
| 81 | response to leptin (GO:0044321) | 3.64245658 |
| 82 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.64145409 |
| 83 | axon extension involved in axon guidance (GO:0048846) | 3.64145409 |
| 84 | positive regulation of gastrulation (GO:2000543) | 3.63359085 |
| 85 | fatty acid homeostasis (GO:0055089) | 3.63263499 |
| 86 | negative regulation of embryonic development (GO:0045992) | 3.62739067 |
| 87 | negative regulation of JUN kinase activity (GO:0043508) | 3.59709790 |
| 88 | endocrine hormone secretion (GO:0060986) | 3.58384255 |
| 89 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.56792387 |
| 90 | negative regulation of granulocyte differentiation (GO:0030853) | 3.56731024 |
| 91 | branching involved in prostate gland morphogenesis (GO:0060442) | 3.54093133 |
| 92 | phagocytosis, recognition (GO:0006910) | 3.53734557 |
| 93 | bone morphogenesis (GO:0060349) | 3.52613883 |
| 94 | hematopoietic stem cell proliferation (GO:0071425) | 3.50905764 |
| 95 | regulation of mesenchymal cell proliferation (GO:0010464) | 3.50359835 |
| 96 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.47167830 |
| 97 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.47167830 |
| 98 | negative regulation of appetite (GO:0032099) | 3.46212792 |
| 99 | negative regulation of response to food (GO:0032096) | 3.46212792 |
| 100 | NADH metabolic process (GO:0006734) | 3.43972568 |
| 101 | negative regulation of macrophage differentiation (GO:0045650) | 3.43255291 |
| 102 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.41877306 |
| 103 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.41410526 |
| 104 | segment specification (GO:0007379) | 3.38510211 |
| 105 | response to BMP (GO:0071772) | 3.38067835 |
| 106 | cellular response to BMP stimulus (GO:0071773) | 3.38067835 |
| 107 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.36221088 |
| 108 | protein localization to cell surface (GO:0034394) | 3.35866785 |
| 109 | negative regulation of epithelial to mesenchymal transition (GO:0010719) | 3.32183712 |
| 110 | positive regulation of mesenchymal cell proliferation (GO:0002053) | 3.31295113 |
| 111 | negative regulation of protein autophosphorylation (GO:0031953) | 3.29330967 |
| 112 | positive regulation of vasculogenesis (GO:2001214) | 3.25308628 |
| 113 | regulation of catenin import into nucleus (GO:0035412) | 3.22786397 |
| 114 | response to epinephrine (GO:0071871) | 3.21069376 |
| 115 | mesodermal cell differentiation (GO:0048333) | 3.20556612 |
| 116 | cell proliferation involved in metanephros development (GO:0072203) | 3.19776857 |
| 117 | cardiac left ventricle morphogenesis (GO:0003214) | 3.19303278 |
| 118 | negative regulation of organic acid transport (GO:0032891) | 3.18724489 |
| 119 | mesenchyme development (GO:0060485) | 3.16567991 |
| 120 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.15968305 |
| 121 | positive regulation of glycolytic process (GO:0045821) | 3.14625910 |
| 122 | negative regulation of cartilage development (GO:0061037) | 3.13688583 |
| 123 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.12759880 |
| 124 | positive regulation of cholesterol efflux (GO:0010875) | 3.11686620 |
| 125 | lung secretory cell differentiation (GO:0061140) | 3.11511512 |
| 126 | positive regulation of glucose import (GO:0046326) | 3.11180511 |
| 127 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.10771220 |
| 128 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.09979245 |
| 129 | brown fat cell differentiation (GO:0050873) | 3.09806792 |
| 130 | regulation of gastrulation (GO:0010470) | 3.09588610 |
| 131 | smooth muscle tissue development (GO:0048745) | 3.09432734 |
| 132 | barbed-end actin filament capping (GO:0051016) | 3.08875100 |
| 133 | endothelium development (GO:0003158) | 3.08691264 |
| 134 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.08005224 |
| 135 | white fat cell differentiation (GO:0050872) | 3.07703531 |
| 136 | ethanol oxidation (GO:0006069) | 3.07076590 |
| 137 | embryonic skeletal joint morphogenesis (GO:0060272) | 3.05243976 |
| 138 | regulation of cell fate commitment (GO:0010453) | 3.04607987 |
| 139 | chondrocyte proliferation (GO:0035988) | 3.04514179 |
| 140 | regulation of morphogenesis of a branching structure (GO:0060688) | 3.03787152 |
| 141 | polyketide metabolic process (GO:0030638) | 3.02943192 |
| 142 | doxorubicin metabolic process (GO:0044598) | 3.02943192 |
| 143 | daunorubicin metabolic process (GO:0044597) | 3.02943192 |
| 144 | branch elongation of an epithelium (GO:0060602) | 3.02492831 |
| 145 | positive regulation of metanephros development (GO:0072216) | 3.02244674 |
| 146 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.02216721 |
| 147 | hippo signaling (GO:0035329) | 3.01866182 |
| 148 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.01232558 |
| 149 | positive regulation of odontogenesis (GO:0042482) | 3.00607092 |
| 150 | positive regulation of lipid storage (GO:0010884) | 2.99157776 |
| 151 | protein heterotrimerization (GO:0070208) | 2.98965349 |
| 152 | negative regulation of metanephros development (GO:0072217) | 2.98784884 |
| 153 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.98578686 |
| 154 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 2.97966971 |
| 155 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.97689361 |
| 156 | desmosome organization (GO:0002934) | 2.97070884 |
| 157 | axis elongation (GO:0003401) | 2.95923098 |
| 158 | post-anal tail morphogenesis (GO:0036342) | 2.94996075 |
| 159 | triglyceride metabolic process (GO:0006641) | 2.92186759 |
| 160 | apoptotic cell clearance (GO:0043277) | 2.92171703 |
| 161 | metanephric mesenchyme development (GO:0072075) | 2.91491737 |
| 162 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.90102187 |
| 163 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.90102187 |
| 164 | ureteric bud development (GO:0001657) | 2.89993276 |
| 165 | regulation of glomerulus development (GO:0090192) | 2.88513484 |
| 166 | middle ear morphogenesis (GO:0042474) | 2.88348334 |
| 167 | retinol metabolic process (GO:0042572) | 2.86354728 |
| 168 | angiogenesis involved in wound healing (GO:0060055) | 2.86302108 |
| 169 | endodermal cell differentiation (GO:0035987) | 2.85691815 |
| 170 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.85674054 |
| 171 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.84767957 |
| 172 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.84640626 |
| 173 | primary alcohol metabolic process (GO:0034308) | 2.84235710 |
| 174 | negative regulation of gluconeogenesis (GO:0045721) | 2.84185426 |
| 175 | endothelial cell morphogenesis (GO:0001886) | 2.83014749 |
| 176 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.82553145 |
| 177 | response to phenylpropanoid (GO:0080184) | 2.81035398 |
| 178 | outer ear morphogenesis (GO:0042473) | 2.80460752 |
| 179 | negative regulation of osteoblast proliferation (GO:0033689) | 2.80016908 |
| 180 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.79989812 |
| 181 | regulation of epithelial to mesenchymal transition (GO:0010717) | 2.79808097 |
| 182 | cellular response to nitric oxide (GO:0071732) | 2.78989274 |
| 183 | response to X-ray (GO:0010165) | 2.78691317 |
| 184 | glycerol metabolic process (GO:0006071) | 2.78640793 |
| 185 | negative regulation of BMP signaling pathway (GO:0030514) | 2.76474278 |
| 186 | camera-type eye morphogenesis (GO:0048593) | 2.75969306 |
| 187 | mesonephric tubule development (GO:0072164) | 2.75781875 |
| 188 | mesonephric epithelium development (GO:0072163) | 2.73599354 |
| 189 | regulation of receptor binding (GO:1900120) | 2.73466430 |
| 190 | triglyceride biosynthetic process (GO:0019432) | 2.71424017 |
| 191 | leukocyte tethering or rolling (GO:0050901) | 2.69151487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.35517786 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 4.51723806 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.96889514 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.58065929 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.33261260 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.25815995 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.95068274 |
| 8 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.64097852 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.52274495 |
| 10 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.43722787 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.42225589 |
| 12 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.23249192 |
| 13 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.20552204 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.15630715 |
| 15 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.08772331 |
| 16 | TP53_18474530_ChIP-ChIP_U2OS_Human | 2.08122453 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.07004365 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.05123879 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.05123879 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.01152481 |
| 21 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.00240541 |
| 22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.98499873 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98197168 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97876348 |
| 25 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.96212538 |
| 26 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.95070780 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.93722134 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.93647870 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.88631494 |
| 30 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.88393594 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.88384193 |
| 32 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.85894397 |
| 33 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.84482712 |
| 34 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.83897416 |
| 35 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.82114538 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.81986536 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.81902321 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.79757519 |
| 39 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.75255657 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.72988314 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71825124 |
| 42 | CJUN_26792858_Chip-Seq_BT549_Human | 1.71688381 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.71443213 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71054894 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.70729050 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.69558055 |
| 47 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.67615026 |
| 48 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.64767237 |
| 49 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.63101242 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60896252 |
| 51 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59304059 |
| 52 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.58845788 |
| 53 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.58508099 |
| 54 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.58320761 |
| 55 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.57628942 |
| 56 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.55186290 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.53031794 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.51472600 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.50563812 |
| 60 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.50563812 |
| 61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50344343 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.50225725 |
| 63 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.49292194 |
| 64 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.49254998 |
| 65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.48883929 |
| 66 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.47670543 |
| 67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.47670543 |
| 68 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.45240107 |
| 69 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.43095918 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41900888 |
| 71 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.41099893 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40745906 |
| 73 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.40313647 |
| 74 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.39893103 |
| 75 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.39466176 |
| 76 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.39165581 |
| 77 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.37932866 |
| 78 | RXR_22108803_ChIP-Seq_LS180_Human | 1.36760450 |
| 79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34891818 |
| 80 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.32012564 |
| 81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31942081 |
| 82 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.31180088 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30515270 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29782596 |
| 85 | EWS_26573619_Chip-Seq_HEK293_Human | 1.27928751 |
| 86 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.26907656 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26870265 |
| 88 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25192549 |
| 89 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.20907190 |
| 90 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20795510 |
| 91 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20768404 |
| 92 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20386773 |
| 93 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.17874038 |
| 94 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17168283 |
| 95 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16720781 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16562065 |
| 97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16153784 |
| 98 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.15807962 |
| 99 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.15347069 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15318631 |
| 101 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14850114 |
| 102 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14815903 |
| 103 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.14119675 |
| 104 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12923748 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.12508919 |
| 106 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11240938 |
| 107 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10922116 |
| 108 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08962551 |
| 109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08288940 |
| 110 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08137511 |
| 111 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08111555 |
| 112 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07652560 |
| 113 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06285357 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05888785 |
| 115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04964991 |
| 116 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.04580892 |
| 117 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03227984 |
| 118 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.02582140 |
| 119 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02105771 |
| 120 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00590348 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00031715 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99580042 |
| 123 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99379208 |
| 124 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.99291692 |
| 125 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97025494 |
| 126 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96368154 |
| 127 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.95594051 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95451382 |
| 129 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95324889 |
| 130 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93864036 |
| 131 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92134595 |
| 132 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.88707761 |
| 133 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.88707761 |
| 134 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.88707761 |
| 135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88148785 |
| 136 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87004770 |
| 137 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84960384 |
| 138 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79924350 |
| 139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77508746 |
| 140 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77360286 |
| 141 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.76896993 |
| 142 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.73199516 |
| 143 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71148695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005503_abnormal_tendon_morphology | 6.32782933 |
| 2 | MP0005670_abnormal_white_adipose | 6.11199500 |
| 3 | MP0004782_abnormal_surfactant_physiolog | 4.49838674 |
| 4 | MP0005666_abnormal_adipose_tissue | 4.37865920 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 4.21104682 |
| 6 | MP0001958_emphysema | 3.77491947 |
| 7 | MP0005275_abnormal_skin_tensile | 3.76670717 |
| 8 | MP0005375_adipose_tissue_phenotype | 3.55823036 |
| 9 | MP0004130_abnormal_muscle_cell | 3.31347385 |
| 10 | MP0000566_synostosis | 2.99145878 |
| 11 | MP0002971_abnormal_brown_adipose | 2.86399086 |
| 12 | MP0010030_abnormal_orbit_morphology | 2.78073996 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.66265819 |
| 14 | MP0008004_abnormal_stomach_pH | 2.62756058 |
| 15 | MP0002876_abnormal_thyroid_physiology | 2.57725229 |
| 16 | MP0000003_abnormal_adipose_tissue | 2.51863022 |
| 17 | MP0008995_early_reproductive_senescence | 2.48549761 |
| 18 | MP0001177_atelectasis | 2.45560508 |
| 19 | MP0004185_abnormal_adipocyte_glucose | 2.44457520 |
| 20 | MP0009115_abnormal_fat_cell | 2.39820532 |
| 21 | MP0003959_abnormal_lean_body | 2.35492284 |
| 22 | MP0006054_spinal_hemorrhage | 2.29570375 |
| 23 | MP0003122_maternal_imprinting | 2.29563126 |
| 24 | MP0000762_abnormal_tongue_morphology | 2.29199323 |
| 25 | MP0000534_abnormal_ureter_morphology | 2.16064776 |
| 26 | MP0005508_abnormal_skeleton_morphology | 2.11555182 |
| 27 | MP0003385_abnormal_body_wall | 2.08800519 |
| 28 | MP0003011_delayed_dark_adaptation | 2.05991492 |
| 29 | MP0009250_abnormal_appendicular_skeleto | 2.04535497 |
| 30 | MP0003941_abnormal_skin_development | 2.01039488 |
| 31 | MP0000751_myopathy | 1.99101386 |
| 32 | MP0003724_increased_susceptibility_to | 1.90133054 |
| 33 | MP0004272_abnormal_basement_membrane | 1.89693209 |
| 34 | MP0000537_abnormal_urethra_morphology | 1.88170743 |
| 35 | MP0002108_abnormal_muscle_morphology | 1.84252655 |
| 36 | MP0005388_respiratory_system_phenotype | 1.82058853 |
| 37 | MP0002133_abnormal_respiratory_system | 1.82058853 |
| 38 | MP0010329_abnormal_lipoprotein_level | 1.80950562 |
| 39 | MP0006138_congestive_heart_failure | 1.79812693 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.76928457 |
| 41 | MP0003828_pulmonary_edema | 1.74789242 |
| 42 | MP0003942_abnormal_urinary_system | 1.74334669 |
| 43 | MP0000049_abnormal_middle_ear | 1.73696549 |
| 44 | MP0002295_abnormal_pulmonary_circulatio | 1.72025762 |
| 45 | MP0001346_abnormal_lacrimal_gland | 1.70386953 |
| 46 | MP0009384_cardiac_valve_regurgitation | 1.70135301 |
| 47 | MP0005367_renal/urinary_system_phenotyp | 1.69143774 |
| 48 | MP0000516_abnormal_urinary_system | 1.69143774 |
| 49 | MP0005334_abnormal_fat_pad | 1.67988137 |
| 50 | MP0003690_abnormal_glial_cell | 1.67276283 |
| 51 | MP0003115_abnormal_respiratory_system | 1.66297236 |
| 52 | MP0003186_abnormal_redox_activity | 1.61287370 |
| 53 | MP0003937_abnormal_limbs/digits/tail_de | 1.59138794 |
| 54 | MP0002249_abnormal_larynx_morphology | 1.59062109 |
| 55 | MP0002970_abnormal_white_adipose | 1.58887751 |
| 56 | MP0002060_abnormal_skin_morphology | 1.55880003 |
| 57 | MP0003755_abnormal_palate_morphology | 1.55283828 |
| 58 | MP0005379_endocrine/exocrine_gland_phen | 1.53005175 |
| 59 | MP0002233_abnormal_nose_morphology | 1.49684239 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.49102594 |
| 61 | MP0002938_white_spotting | 1.48100265 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.47887744 |
| 63 | MP0003121_genomic_imprinting | 1.45546729 |
| 64 | MP0003935_abnormal_craniofacial_develop | 1.44431556 |
| 65 | MP0002909_abnormal_adrenal_gland | 1.44349598 |
| 66 | MP0000428_abnormal_craniofacial_morphol | 1.40607824 |
| 67 | MP0005535_abnormal_body_temperature | 1.39761902 |
| 68 | MP0000383_abnormal_hair_follicle | 1.39693714 |
| 69 | MP0003950_abnormal_plasma_membrane | 1.39482874 |
| 70 | MP0001293_anophthalmia | 1.36109323 |
| 71 | MP0002932_abnormal_joint_morphology | 1.36078901 |
| 72 | MP0002109_abnormal_limb_morphology | 1.34315546 |
| 73 | MP0000681_abnormal_thyroid_gland | 1.34211742 |
| 74 | MP0003868_abnormal_feces_composition | 1.33360685 |
| 75 | MP0000432_abnormal_head_morphology | 1.31333595 |
| 76 | MP0005595_abnormal_vascular_smooth | 1.26136768 |
| 77 | MP0001175_abnormal_lung_morphology | 1.26088964 |
| 78 | MP0001270_distended_abdomen | 1.25136289 |
| 79 | MP0003279_aneurysm | 1.25048139 |
| 80 | MP0002933_joint_inflammation | 1.23437792 |
| 81 | MP0001340_abnormal_eyelid_morphology | 1.22956388 |
| 82 | MP0000613_abnormal_salivary_gland | 1.22921529 |
| 83 | MP0009780_abnormal_chondrocyte_physiolo | 1.22019860 |
| 84 | MP0003123_paternal_imprinting | 1.21773832 |
| 85 | MP0002116_abnormal_craniofacial_bone | 1.21555881 |
| 86 | MP0000163_abnormal_cartilage_morphology | 1.21303729 |
| 87 | MP0002282_abnormal_trachea_morphology | 1.21163563 |
| 88 | MP0003890_abnormal_embryonic-extraembry | 1.18461179 |
| 89 | MP0005076_abnormal_cell_differentiation | 1.18217775 |
| 90 | MP0010678_abnormal_skin_adnexa | 1.15684812 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 1.15217731 |
| 92 | MP0005448_abnormal_energy_balance | 1.14031061 |
| 93 | MP0006276_abnormal_autonomic_nervous | 1.12545951 |
| 94 | MP0001542_abnormal_bone_strength | 1.10025654 |
| 95 | MP0003787_abnormal_imprinting | 1.09942080 |
| 96 | MP0002098_abnormal_vibrissa_morphology | 1.09189432 |
| 97 | MP0002115_abnormal_skeleton_extremities | 1.08743485 |
| 98 | MP0000343_altered_response_to | 1.08363621 |
| 99 | MP0001544_abnormal_cardiovascular_syste | 1.07048352 |
| 100 | MP0005385_cardiovascular_system_phenoty | 1.07048352 |
| 101 | MP0001661_extended_life_span | 1.06869415 |
| 102 | MP0009053_abnormal_anal_canal | 1.06283374 |
| 103 | MP0002118_abnormal_lipid_homeostasis | 1.06136704 |
| 104 | MP0002113_abnormal_skeleton_development | 1.04875336 |
| 105 | MP0003119_abnormal_digestive_system | 1.04874423 |
| 106 | MP0004215_abnormal_myocardial_fiber | 1.04779566 |
| 107 | MP0000462_abnormal_digestive_system | 1.01662612 |
| 108 | MP0010234_abnormal_vibrissa_follicle | 1.01376628 |
| 109 | MP0002896_abnormal_bone_mineralization | 1.00694173 |
| 110 | MP0003705_abnormal_hypodermis_morpholog | 1.00592522 |
| 111 | MP0000579_abnormal_nail_morphology | 1.00403589 |
| 112 | MP0002638_abnormal_pupillary_reflex | 0.99859906 |
| 113 | MP0000759_abnormal_skeletal_muscle | 0.97753865 |
| 114 | MP0002111_abnormal_tail_morphology | 0.90321150 |
| 115 | MP0005452_abnormal_adipose_tissue | 0.88887595 |
| 116 | MP0005164_abnormal_response_to | 0.87942710 |
| 117 | MP0004087_abnormal_muscle_fiber | 0.87193227 |
| 118 | MP0002177_abnormal_outer_ear | 0.86976235 |
| 119 | MP0001286_abnormal_eye_development | 0.85924906 |
| 120 | MP0003938_abnormal_ear_development | 0.85856453 |
| 121 | MP0005023_abnormal_wound_healing | 0.84868954 |
| 122 | MP0005390_skeleton_phenotype | 0.84559980 |
| 123 | MP0003091_abnormal_cell_migration | 0.83877824 |
| 124 | MP0000427_abnormal_hair_cycle | 0.83022742 |
| 125 | MP0005248_abnormal_Harderian_gland | 0.82984472 |
| 126 | MP0001299_abnormal_eye_distance/ | 0.82202912 |
| 127 | MP0005171_absent_coat_pigmentation | 0.82068544 |
| 128 | MP0001501_abnormal_sleep_pattern | 0.81752591 |
| 129 | MP0005369_muscle_phenotype | 0.81489275 |
| 130 | MP0004134_abnormal_chest_morphology | 0.79790523 |
| 131 | MP0001879_abnormal_lymphatic_vessel | 0.79422650 |
| 132 | MP0000767_abnormal_smooth_muscle | 0.79326279 |
| 133 | MP0003948_abnormal_gas_homeostasis | 0.78742287 |
| 134 | MP0004484_altered_response_of | 0.78377622 |
| 135 | MP0000733_abnormal_muscle_development | 0.78282875 |
| 136 | MP0004264_abnormal_extraembryonic_tissu | 0.76654129 |
| 137 | MP0000249_abnormal_blood_vessel | 0.76413550 |
| 138 | MP0000678_abnormal_parathyroid_gland | 0.73847248 |
| 139 | MP0002277_abnormal_respiratory_mucosa | 0.73425255 |
| 140 | MP0002234_abnormal_pharynx_morphology | 0.73216403 |
| 141 | MP0001849_ear_inflammation | 0.72596235 |
| 142 | MP0003191_abnormal_cellular_cholesterol | 0.72581093 |
| 143 | MP0000750_abnormal_muscle_regeneration | 0.72384427 |
| 144 | MP0001851_eye_inflammation | 0.71713969 |
| 145 | MP0002114_abnormal_axial_skeleton | 0.69026072 |
| 146 | MP0002925_abnormal_cardiovascular_devel | 0.68337259 |
| 147 | MP0001943_abnormal_respiration | 0.68187699 |
| 148 | MP0000858_altered_metastatic_potential | 0.66834628 |
| 149 | MP0009703_decreased_birth_body | 0.66788161 |
| 150 | MP0005620_abnormal_muscle_contractility | 0.65121168 |
| 151 | MP0010771_integument_phenotype | 0.64010895 |
| 152 | MP0001614_abnormal_blood_vessel | 0.62082176 |
| 153 | MP0003448_altered_tumor_morphology | 0.61631731 |
| 154 | MP0001243_abnormal_dermal_layer | 0.61030039 |
| 155 | MP0002697_abnormal_eye_size | 0.60383618 |
| 156 | MP0002078_abnormal_glucose_homeostasis | 0.59806721 |
| 157 | MP0002128_abnormal_blood_circulation | 0.57815923 |
| 158 | MP0000747_muscle_weakness | 0.57716104 |
| 159 | MP0000230_abnormal_systemic_arterial | 0.56278733 |
| 160 | MP0005647_abnormal_sex_gland | 0.54635784 |
| 161 | MP0001764_abnormal_homeostasis | 0.53950534 |
| 162 | MP0001533_abnormal_skeleton_physiology | 0.51360226 |
| 163 | MP0010630_abnormal_cardiac_muscle | 0.49875117 |
| 164 | MP0002998_abnormal_bone_remodeling | 0.46438855 |
| 165 | MP0000749_muscle_degeneration | 0.46296080 |
| 166 | MP0005623_abnormal_meninges_morphology | 0.46271232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 6.70365355 |
| 2 | Interstitial pulmonary disease (HP:0006530) | 6.03044075 |
| 3 | Acanthosis nigricans (HP:0000956) | 5.31845633 |
| 4 | Hypertriglyceridemia (HP:0002155) | 4.73992778 |
| 5 | Shallow orbits (HP:0000586) | 4.44051899 |
| 6 | Increased variability in muscle fiber diameter (HP:0003557) | 4.37104712 |
| 7 | Atrophic scars (HP:0001075) | 4.19703382 |
| 8 | Protrusio acetabuli (HP:0003179) | 3.98732043 |
| 9 | Vertebral compression fractures (HP:0002953) | 3.93083905 |
| 10 | Vascular tortuosity (HP:0004948) | 3.78977011 |
| 11 | Tubulointerstitial fibrosis (HP:0005576) | 3.71264642 |
| 12 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.61934137 |
| 13 | Broad metatarsal (HP:0001783) | 3.59570394 |
| 14 | Microglossia (HP:0000171) | 3.57710193 |
| 15 | Respiratory distress (HP:0002098) | 3.57489845 |
| 16 | Onycholysis (HP:0001806) | 3.34951810 |
| 17 | Cervical subluxation (HP:0003308) | 3.30846628 |
| 18 | Spinal rigidity (HP:0003306) | 3.24843115 |
| 19 | Cerebral aneurysm (HP:0004944) | 3.23805170 |
| 20 | Premature rupture of membranes (HP:0001788) | 3.23759539 |
| 21 | Abnormality of the parietal bone (HP:0002696) | 3.22314927 |
| 22 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.20221715 |
| 23 | Short 4th metacarpal (HP:0010044) | 3.20221715 |
| 24 | Asymmetry of the thorax (HP:0001555) | 3.18049514 |
| 25 | Follicular hyperkeratosis (HP:0007502) | 3.15896965 |
| 26 | Abnormal eating behavior (HP:0100738) | 3.15727339 |
| 27 | Insulin resistance (HP:0000855) | 3.11125847 |
| 28 | Coronal craniosynostosis (HP:0004440) | 3.10563503 |
| 29 | Arterial tortuosity (HP:0005116) | 3.06082038 |
| 30 | Dilatation of the ascending aorta (HP:0005111) | 3.01640873 |
| 31 | Striae distensae (HP:0001065) | 2.92013060 |
| 32 | Abnormality of the 2nd finger (HP:0004100) | 2.89060429 |
| 33 | Wormian bones (HP:0002645) | 2.81307388 |
| 34 | Ankle contracture (HP:0006466) | 2.77539893 |
| 35 | Back pain (HP:0003418) | 2.77479830 |
| 36 | Morphological abnormality of the middle ear (HP:0008609) | 2.77197533 |
| 37 | Cutaneous finger syndactyly (HP:0010554) | 2.76430659 |
| 38 | Bell-shaped thorax (HP:0001591) | 2.75363263 |
| 39 | Complement deficiency (HP:0004431) | 2.73062441 |
| 40 | Difficulty running (HP:0009046) | 2.71477988 |
| 41 | Skin nodule (HP:0200036) | 2.66617785 |
| 42 | Turricephaly (HP:0000262) | 2.65360889 |
| 43 | Abnormality of the nasolacrimal system (HP:0000614) | 2.64880058 |
| 44 | Bone cyst (HP:0012062) | 2.62965377 |
| 45 | Abnormality of complement system (HP:0005339) | 2.60162262 |
| 46 | Absent eyebrow (HP:0002223) | 2.59564806 |
| 47 | Tachypnea (HP:0002789) | 2.58985335 |
| 48 | Wide anterior fontanel (HP:0000260) | 2.58587801 |
| 49 | Polycythemia (HP:0001901) | 2.57431450 |
| 50 | Prominent supraorbital ridges (HP:0000336) | 2.56595731 |
| 51 | Midline defect of the nose (HP:0004122) | 2.54164289 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.53490028 |
| 53 | Down-sloping shoulders (HP:0200021) | 2.53346226 |
| 54 | Hyperlipoproteinemia (HP:0010980) | 2.52862515 |
| 55 | Muscle fiber splitting (HP:0003555) | 2.52533113 |
| 56 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.51819561 |
| 57 | Infantile muscular hypotonia (HP:0008947) | 2.51502530 |
| 58 | Mesomelia (HP:0003027) | 2.49959592 |
| 59 | Peritonitis (HP:0002586) | 2.48833504 |
| 60 | Abnormality of incisor morphology (HP:0011063) | 2.46841336 |
| 61 | Milia (HP:0001056) | 2.45877015 |
| 62 | Breech presentation (HP:0001623) | 2.45602235 |
| 63 | Fragile nails (HP:0001808) | 2.41708818 |
| 64 | Type 1 muscle fiber predominance (HP:0003803) | 2.40515794 |
| 65 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.36012199 |
| 66 | Pigmentary retinal degeneration (HP:0001146) | 2.35773284 |
| 67 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.34371007 |
| 68 | Osteolytic defects of the hand bones (HP:0009699) | 2.34371007 |
| 69 | Abnormality of the lacrimal duct (HP:0011481) | 2.33876537 |
| 70 | Cutaneous syndactyly (HP:0012725) | 2.32651075 |
| 71 | Hypoplastic labia majora (HP:0000059) | 2.31369082 |
| 72 | Distal arthrogryposis (HP:0005684) | 2.31095126 |
| 73 | Neonatal short-limb short stature (HP:0008921) | 2.29660291 |
| 74 | Hepatoblastoma (HP:0002884) | 2.27914617 |
| 75 | Nasolacrimal duct obstruction (HP:0000579) | 2.27554041 |
| 76 | Overgrowth (HP:0001548) | 2.27000997 |
| 77 | Increased connective tissue (HP:0009025) | 2.26631126 |
| 78 | Pulmonary artery stenosis (HP:0004415) | 2.26256191 |
| 79 | Abnormal hemoglobin (HP:0011902) | 2.25931373 |
| 80 | Hyperactive renin-angiotensin system (HP:0000841) | 2.24810366 |
| 81 | Aortic dissection (HP:0002647) | 2.24788607 |
| 82 | Fragile skin (HP:0001030) | 2.24366160 |
| 83 | Long nose (HP:0003189) | 2.23829969 |
| 84 | Round ear (HP:0100830) | 2.23760169 |
| 85 | Accelerated skeletal maturation (HP:0005616) | 2.22459600 |
| 86 | Biconcave vertebral bodies (HP:0004586) | 2.22046666 |
| 87 | Severe Myopia (HP:0011003) | 2.20591704 |
| 88 | Tubulointerstitial abnormality (HP:0001969) | 2.20395097 |
| 89 | Lipoatrophy (HP:0100578) | 2.18127736 |
| 90 | Growth hormone excess (HP:0000845) | 2.17814004 |
| 91 | Soft skin (HP:0000977) | 2.17798552 |
| 92 | Hemorrhage of the eye (HP:0011885) | 2.17632839 |
| 93 | Hypoplasia of the iris (HP:0007676) | 2.16616027 |
| 94 | Frequent falls (HP:0002359) | 2.15328858 |
| 95 | Buphthalmos (HP:0000557) | 2.15110208 |
| 96 | Abnormal delivery (HP:0001787) | 2.14277729 |
| 97 | Synostosis involving the elbow (HP:0003938) | 2.12744877 |
| 98 | Humeroradial synostosis (HP:0003041) | 2.12744877 |
| 99 | Joint laxity (HP:0001388) | 2.11246679 |
| 100 | Broad toe (HP:0001837) | 2.11084362 |
| 101 | Abnormality of the 4th metacarpal (HP:0010012) | 2.10962425 |
| 102 | Renal hypoplasia (HP:0000089) | 2.10959809 |
| 103 | Thyroid-stimulating hormone excess (HP:0002925) | 2.09644240 |
| 104 | Increased number of teeth (HP:0011069) | 2.09467601 |
| 105 | Myocardial infarction (HP:0001658) | 2.08969855 |
| 106 | Venous abnormality (HP:0002624) | 2.07587742 |
| 107 | Corneal dystrophy (HP:0001131) | 2.07360770 |
| 108 | Venous insufficiency (HP:0005293) | 2.06728272 |
| 109 | Lymphangioma (HP:0100764) | 2.05335696 |
| 110 | Hypercortisolism (HP:0001578) | 2.03217569 |
| 111 | Tubular atrophy (HP:0000092) | 2.03169183 |
| 112 | Abnormality of the labia majora (HP:0012881) | 2.02860507 |
| 113 | Short middle phalanx of the 5th finger (HP:0004220) | 2.01784865 |
| 114 | Aneurysm (HP:0002617) | 2.01256424 |
| 115 | Glomerulonephritis (HP:0000099) | 2.00933198 |
| 116 | Nephritis (HP:0000123) | 2.00580942 |
| 117 | Camptodactyly of toe (HP:0001836) | 1.99673056 |
| 118 | Abnormality of the nasal septum (HP:0000419) | 1.98805102 |
| 119 | Blue sclerae (HP:0000592) | 1.98766561 |
| 120 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.98582796 |
| 121 | Aplasia of the phalanges of the hand (HP:0009802) | 1.98582796 |
| 122 | Aplasia involving bones of the extremities (HP:0009825) | 1.98582796 |
| 123 | Coxa vara (HP:0002812) | 1.96307863 |
| 124 | Ulnar bowing (HP:0003031) | 1.96092053 |
| 125 | Neck muscle weakness (HP:0000467) | 1.94071811 |
| 126 | Cupped ribs (HP:0000887) | 1.93380728 |
| 127 | Congenital sensorineural hearing impairment (HP:0008527) | 1.93364418 |
| 128 | Narrow nasal bridge (HP:0000446) | 1.92914508 |
| 129 | Sparse lateral eyebrow (HP:0005338) | 1.91970142 |
| 130 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.91469837 |
| 131 | Protruding ear (HP:0000411) | 1.90934448 |
| 132 | Gowers sign (HP:0003391) | 1.90889348 |
| 133 | Metaphyseal dysplasia (HP:0100255) | 1.90504453 |
| 134 | Short middle phalanx of finger (HP:0005819) | 1.90455600 |
| 135 | Genu recurvatum (HP:0002816) | 1.89695781 |
| 136 | Stomach cancer (HP:0012126) | 1.88607921 |
| 137 | Asymmetric septal hypertrophy (HP:0001670) | 1.87791789 |
| 138 | Partial duplication of the phalanx of hand (HP:0009999) | 1.87115651 |
| 139 | Amyloidosis (HP:0011034) | 1.87041112 |
| 140 | Disproportionate tall stature (HP:0001519) | 1.86995346 |
| 141 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.86935258 |
| 142 | Tracheomalacia (HP:0002779) | 1.86619370 |
| 143 | Hypoplasia of the maxilla (HP:0000327) | 1.86462321 |
| 144 | Aortic valve stenosis (HP:0001650) | 1.85289739 |
| 145 | Deviation of the hallux (HP:0010051) | 1.84998797 |
| 146 | Narrow palate (HP:0000189) | 1.84457891 |
| 147 | Hallux valgus (HP:0001822) | 1.84056691 |
| 148 | Joint stiffness (HP:0001387) | 1.84022447 |
| 149 | Trigonocephaly (HP:0000243) | 1.83631541 |
| 150 | Delayed cranial suture closure (HP:0000270) | 1.81247180 |
| 151 | Osteoarthritis (HP:0002758) | 1.81154690 |
| 152 | Tubulointerstitial nephritis (HP:0001970) | 1.80163031 |
| 153 | Oligodontia (HP:0000677) | 1.79615444 |
| 154 | Joint contractures involving the joints of the feet (HP:0100492) | 1.79457142 |
| 155 | Flexion contracture of toe (HP:0005830) | 1.79457142 |
| 156 | Long toe (HP:0010511) | 1.78021792 |
| 157 | Abnormality of dentin (HP:0010299) | 1.77636090 |
| 158 | Hyperextensible skin (HP:0000974) | 1.76839794 |
| 159 | Ovoid vertebral bodies (HP:0003300) | 1.76748937 |
| 160 | Mitral regurgitation (HP:0001653) | 1.76627418 |
| 161 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.76613831 |
| 162 | Lip pit (HP:0100267) | 1.76173115 |
| 163 | Mitral valve prolapse (HP:0001634) | 1.75817315 |
| 164 | Anophthalmia (HP:0000528) | 1.75749527 |
| 165 | Choanal stenosis (HP:0000452) | 1.75071471 |
| 166 | Renal salt wasting (HP:0000127) | 1.74258934 |
| 167 | Knee flexion contracture (HP:0006380) | 1.74015646 |
| 168 | Bladder diverticulum (HP:0000015) | 1.74003864 |
| 169 | Sprengel anomaly (HP:0000912) | 1.73728471 |
| 170 | Abnormality of the middle phalanges of the hand (HP:0009833) | 1.71359908 |
| 171 | Ectopia lentis (HP:0001083) | 1.70988179 |
| 172 | Flat cornea (HP:0007720) | 1.69432731 |
| 173 | Neonatal respiratory distress (HP:0002643) | 1.69253361 |
| 174 | Bifid scrotum (HP:0000048) | 1.68296573 |
| 175 | Broad hallux (HP:0010055) | 1.67806530 |
| 176 | Abnormality of the right ventricle (HP:0001707) | 1.67160899 |
| 177 | Aortic aneurysm (HP:0004942) | 1.65895424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 5.26608341 |
| 2 | EPHA3 | 4.78940228 |
| 3 | FGFR2 | 4.24585143 |
| 4 | STK24 | 3.65930387 |
| 5 | SIK1 | 3.45733612 |
| 6 | ACVR1B | 3.03573067 |
| 7 | EPHB2 | 2.99590738 |
| 8 | TRIB3 | 2.88890653 |
| 9 | FRK | 2.80368199 |
| 10 | DDR2 | 2.45913574 |
| 11 | BMPR1B | 2.45028976 |
| 12 | STK3 | 2.31824970 |
| 13 | TESK1 | 2.26967321 |
| 14 | ARAF | 2.09750213 |
| 15 | SIK3 | 2.04499181 |
| 16 | CAMK1 | 1.91919211 |
| 17 | MOS | 1.87098573 |
| 18 | GRK5 | 1.84367461 |
| 19 | PRKAA2 | 1.80896763 |
| 20 | ABL2 | 1.69194421 |
| 21 | MAP3K13 | 1.69033096 |
| 22 | STK38L | 1.67205616 |
| 23 | NUAK1 | 1.62699923 |
| 24 | MAP3K6 | 1.61887277 |
| 25 | KIT | 1.56533605 |
| 26 | EPHA4 | 1.55437092 |
| 27 | CASK | 1.48939900 |
| 28 | MAPK4 | 1.46772590 |
| 29 | TGFBR1 | 1.42947509 |
| 30 | LMTK2 | 1.37718750 |
| 31 | MELK | 1.32794010 |
| 32 | FER | 1.28484598 |
| 33 | MAPK7 | 1.28221508 |
| 34 | ERBB3 | 1.27537584 |
| 35 | TGFBR2 | 1.23750755 |
| 36 | AKT3 | 1.17377228 |
| 37 | PDGFRA | 1.17216477 |
| 38 | SGK2 | 1.16693719 |
| 39 | MET | 1.16313234 |
| 40 | CDK6 | 1.15092270 |
| 41 | PLK2 | 1.14699264 |
| 42 | PDGFRB | 1.14027996 |
| 43 | RPS6KA4 | 1.12909358 |
| 44 | ZAK | 1.12376720 |
| 45 | LATS2 | 1.11832106 |
| 46 | PIK3CA | 1.11174771 |
| 47 | PAK4 | 1.11121312 |
| 48 | FGFR3 | 1.09332463 |
| 49 | MAPKAPK3 | 1.08302581 |
| 50 | EEF2K | 1.07960557 |
| 51 | LRRK2 | 1.07674978 |
| 52 | MST1R | 1.06815705 |
| 53 | WNK1 | 1.03634968 |
| 54 | DAPK2 | 1.03116423 |
| 55 | KSR2 | 0.99934732 |
| 56 | FGFR1 | 0.97503436 |
| 57 | CSK | 0.96316000 |
| 58 | INSRR | 0.95950650 |
| 59 | NEK9 | 0.95857969 |
| 60 | TYK2 | 0.93980897 |
| 61 | CAMK1D | 0.92643792 |
| 62 | SGK3 | 0.90944818 |
| 63 | MAPK12 | 0.90286680 |
| 64 | PRKG1 | 0.89164281 |
| 65 | DMPK | 0.88829773 |
| 66 | PRKCE | 0.86306092 |
| 67 | RIPK1 | 0.85687263 |
| 68 | FGFR4 | 0.83485021 |
| 69 | ERBB2 | 0.83226841 |
| 70 | EPHA2 | 0.79827982 |
| 71 | CHUK | 0.79609640 |
| 72 | ILK | 0.75869626 |
| 73 | KDR | 0.75649901 |
| 74 | MARK1 | 0.75375334 |
| 75 | PDPK1 | 0.73827391 |
| 76 | ZAP70 | 0.73814756 |
| 77 | PAK2 | 0.73596267 |
| 78 | EIF2AK2 | 0.73036911 |
| 79 | GRK1 | 0.72979725 |
| 80 | CDK8 | 0.72498222 |
| 81 | TIE1 | 0.71681630 |
| 82 | ERN1 | 0.71590786 |
| 83 | PRKAA1 | 0.70354104 |
| 84 | GSK3A | 0.67166616 |
| 85 | CDK3 | 0.66737068 |
| 86 | PKN2 | 0.64904369 |
| 87 | BCR | 0.64164296 |
| 88 | PRKACG | 0.63243236 |
| 89 | ADRBK1 | 0.61836107 |
| 90 | JAK2 | 0.60752394 |
| 91 | ROCK1 | 0.59893593 |
| 92 | RET | 0.58345113 |
| 93 | STK4 | 0.56476949 |
| 94 | MAP3K9 | 0.51636961 |
| 95 | TBK1 | 0.51341608 |
| 96 | PTK2B | 0.50609071 |
| 97 | MST4 | 0.48789714 |
| 98 | PTK2 | 0.48748113 |
| 99 | ABL1 | 0.48641190 |
| 100 | BMX | 0.47899504 |
| 101 | CAMKK2 | 0.47863215 |
| 102 | SGK494 | 0.47819301 |
| 103 | SGK223 | 0.47819301 |
| 104 | MAPK15 | 0.47661360 |
| 105 | INSR | 0.47488333 |
| 106 | NLK | 0.47387547 |
| 107 | MAPK3 | 0.47156849 |
| 108 | MAP3K3 | 0.47089348 |
| 109 | SRC | 0.46110381 |
| 110 | PKN1 | 0.45892678 |
| 111 | PLK3 | 0.45070671 |
| 112 | JAK1 | 0.44488056 |
| 113 | PRKACB | 0.43977357 |
| 114 | CSNK1A1L | 0.43911077 |
| 115 | RIPK4 | 0.43094571 |
| 116 | TYRO3 | 0.42329262 |
| 117 | IGF1R | 0.42139578 |
| 118 | MYLK | 0.42014841 |
| 119 | CAMK1G | 0.41905343 |
| 120 | PRKD1 | 0.39482031 |
| 121 | FES | 0.39299085 |
| 122 | MAPKAPK5 | 0.39017566 |
| 123 | CDK12 | 0.38959641 |
| 124 | PRKCQ | 0.38769275 |
| 125 | MAP2K1 | 0.38598155 |
| 126 | PTK6 | 0.38207592 |
| 127 | JAK3 | 0.37678991 |
| 128 | BRD4 | 0.37595287 |
| 129 | EPHB1 | 0.36277426 |
| 130 | DAPK3 | 0.35381513 |
| 131 | MAP3K7 | 0.32839461 |
| 132 | MAPK1 | 0.31762450 |
| 133 | FLT3 | 0.31552689 |
| 134 | CDK5 | 0.31514831 |
| 135 | RPS6KA3 | 0.30912058 |
| 136 | PRPF4B | 0.30539677 |
| 137 | CDC42BPA | 0.27832994 |
| 138 | HIPK2 | 0.27628282 |
| 139 | RPS6KA2 | 0.27143127 |
| 140 | CAMK4 | 0.26935778 |
| 141 | CSNK1G1 | 0.26935741 |
| 142 | CSF1R | 0.26828536 |
| 143 | PRKCZ | 0.26725653 |
| 144 | PRKCD | 0.26614034 |
| 145 | STK38 | 0.26184036 |
| 146 | MARK2 | 0.25564999 |
| 147 | PRKCG | 0.24694287 |
| 148 | PRKACA | 0.24263109 |
| 149 | MAPK8 | 0.23855339 |
| 150 | YES1 | 0.23455717 |
| 151 | CDK9 | 0.23348000 |
| 152 | TRPM7 | 0.22578814 |
| 153 | NTRK1 | 0.22152782 |
| 154 | MTOR | 0.21994152 |
| 155 | AKT2 | 0.21985644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.27221343 |
| 2 | Basal cell carcinoma_Homo sapiens_hsa05217 | 3.52425423 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.32654719 |
| 4 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.11204488 |
| 5 | Adherens junction_Homo sapiens_hsa04520 | 2.90245768 |
| 6 | Hippo signaling pathway_Homo sapiens_hsa04390 | 2.84349455 |
| 7 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.66224005 |
| 8 | Wnt signaling pathway_Homo sapiens_hsa04310 | 2.33400088 |
| 9 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 2.25753144 |
| 10 | Mineral absorption_Homo sapiens_hsa04978 | 2.23797080 |
| 11 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.21682202 |
| 12 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.12360862 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.10420975 |
| 14 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 2.06938417 |
| 15 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.04940810 |
| 16 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.03105733 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.99204863 |
| 18 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.98100853 |
| 19 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.92506534 |
| 20 | Axon guidance_Homo sapiens_hsa04360 | 1.87578398 |
| 21 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.85086904 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.85065273 |
| 23 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.83911486 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.78474671 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74928279 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.70455413 |
| 27 | Melanoma_Homo sapiens_hsa05218 | 1.67968777 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67050827 |
| 29 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.61309954 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.60932571 |
| 31 | Prostate cancer_Homo sapiens_hsa05215 | 1.53459587 |
| 32 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.53380517 |
| 33 | Melanogenesis_Homo sapiens_hsa04916 | 1.51635830 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.51310706 |
| 35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.44799464 |
| 36 | Tight junction_Homo sapiens_hsa04530 | 1.43377768 |
| 37 | Bladder cancer_Homo sapiens_hsa05219 | 1.43374888 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.42180836 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41405012 |
| 40 | Pathways in cancer_Homo sapiens_hsa05200 | 1.39860895 |
| 41 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.36594726 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 1.32865770 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29060449 |
| 44 | Endometrial cancer_Homo sapiens_hsa05213 | 1.25575134 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22917138 |
| 46 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.21553781 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13664591 |
| 48 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.12027285 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06251085 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.05838756 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05496367 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04825977 |
| 53 | Thyroid cancer_Homo sapiens_hsa05216 | 1.02876286 |
| 54 | Colorectal cancer_Homo sapiens_hsa05210 | 1.00966629 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00378967 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.99791806 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99290456 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.97529251 |
| 59 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.96113078 |
| 60 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.95692859 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.95464888 |
| 62 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.92450815 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91032283 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89180063 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.87389644 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.86830691 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85560044 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84518390 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83346322 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82876110 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82455673 |
| 72 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81461474 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.81134073 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79034011 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78882690 |
| 76 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78819203 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78320182 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76838611 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76117184 |
| 80 | Taste transduction_Homo sapiens_hsa04742 | 0.75428464 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74164050 |
| 82 | Gap junction_Homo sapiens_hsa04540 | 0.73975394 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72547277 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.72469539 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.72204277 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67764349 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64384527 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64088583 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.63782449 |
| 90 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63608564 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.59648159 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59036354 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58944819 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58938669 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.58836547 |
| 96 | Cell cycle_Homo sapiens_hsa04110 | 0.58415530 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58011398 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57024344 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56672096 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56222011 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56199870 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55321137 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55176089 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.54194805 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54105796 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53548647 |
| 107 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53214631 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52886830 |
| 109 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52487688 |
| 110 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51740840 |
| 111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51273041 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50987824 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50828296 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50669887 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50319508 |
| 116 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.50309900 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50126104 |
| 118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50093993 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.50031008 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50020483 |
| 121 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49778877 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49587792 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48438280 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47935962 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45333982 |
| 126 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43770805 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43309234 |
| 128 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42622687 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42368443 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40815127 |
| 131 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40225245 |
| 132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39149373 |
| 133 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39088001 |
| 134 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.38404138 |
| 135 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38387702 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38035136 |
| 137 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37500188 |
| 138 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37165182 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.36741500 |
| 140 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35342103 |
| 141 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34772573 |
| 142 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34547898 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34241103 |
| 144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32613634 |
| 145 | Bile secretion_Homo sapiens_hsa04976 | 0.32078737 |
| 146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31565339 |
| 147 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31237719 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.30643481 |

